NEW YORK, NY / ACCESSWIRE / December 19, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Grubhub Inc. (NYSE:GRUB)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/grubhub-inc-loss-submission-form?prid=4964&wire=1
Lead Plaintiff Deadline: January 20, 2020
Class Period: July 30, 2019 to October 28, 2019

Allegations against GRUB include that: (i) customer orders were actually declining, despite the massive investments that the Company had made to spur demand for and use of its platform; (ii) Grubhub's new customer additions were generating significantly lower revenues as compared to historic cohorts because these customers were more prone to using competitor platforms; (iii) Grubhub's vaunted business model under which it secured exclusive partnerships had failed, and Grubhub needed to engage in the same aggressive nonpartnered sales tactics embraced by its competitors to generate significant revenue growth; (iv) Grubhub was required to spend substantial additional capital in order to grow revenues and retain market share in the face of heightened competitive dynamics and market saturation, eviscerating the Company's profitability; and (v) Grubhub was tracking tens of millions of dollars below its revenue and earnings guidance and such guidance lacked any reasonable basis.

Aurora Cannabis Inc. (NYSE:ACB)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/aurora-cannabis-inc-loss-submission-form?prid=4964&wire=1
Lead Plaintiff Deadline: January 21, 2020
Class Period: September 11, 2019 to November 14, 2019

Allegations against ACB include that: (1) as opposed to the Company's representations, Aurora's revenue would decline in its first quarter of fiscal 2020 ended September 30, 2019; (2) the Company would halt construction on its Aurora Nordic 2 and Aurora Sun facilities; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

HEXO Corp. (NYSE:HEXO)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/hexo-corp-loss-submission-form?prid=4964&wire=1
Lead Plaintiff Deadline: January 27, 2020
Class Period: January 25, 2019 to November 15, 2019

Allegations against HEXO include that: (1) HEXO's reported inventory was misstated as the Company was failing to write down or write off obsolete product that no longer had value; (2) HEXO was engaging in channel-stuffing in order to inflate its revenue figures and meet or exceed revenue guidance provided to investors; (3) HEXO was cultivating cannabis at its facility in Niagara, Ontario that was not appropriately licensed by Health Canada; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 570795

TEL AVIV, ISRAEL / ACCESSWIRE / December 19, 2019 / FIRST BITCOIN CAPITAL CORP (OTC PINK:BITCF) ("the Company") is pleased to announce that it has released its financial results for the 9 months ending September 30 2019.

For the nine months ending September 30 2019, First Bitcoin's assets, compared to the year ending 2018, increased from US$365,352 to $660,313. Also in 2019 asset gains were partially a result of exchanging, for preferred convertible shares, 1,000,000,000 of the Company's mineable cryptocurrency First Bitcoin (COIN:BIT) which coin's history of trading can be followed via coinmarketcap.com

The majority of our cryptocurrency assets are not reflected as showing any value on our balance sheet due to reporting those assets at our zero cost basis, as to the Company having been the generator of those assets. We also show no value on our balance sheet to the US$1,000,000 convertible note receivable that we exchange for 600,000,000 BITs since it is convertible into a thinly traded sub penny stock.

Liabilities decreased from US$258,597 to $145,423.

First Bitcoin has endeavoured to complete its nine months of unaudited financial statements with the intention to list on the CSE and resume trading on a higher market in the USA which we anticipate accomplishing soon after our form 20-F is filed in the USA and Canada.

Our audited and unaudited financial statements can be viewed here: https://firstbitcoin.io/investors/

About First Bitcoin Capital Corp

First Bitcoin Capital Corp (OTC Expert Market:BITCF) began developing digital currencies, proprietary blockchain technologies, and the digital currency exchange – www.CoinQX.com (in Beta) in early 2014. We saw this step as a tremendous opportunity to create further shareholder value by leveraging management's experience in developing and managing complex blockchain technologies and in developing new types of digital assets. Being the first publicly traded cryptocurrency and blockchain-centered company, we provide our shareholders with diversified exposure to digital cryptocurrencies and blockchain technologies.

The Company began developing its own blockchain and cryptocurrency called First Bitcoin (COIN: BIT) in 2016. Recently the Company updated the BIT wallet and added more functionality. Users are able to generate BIT through the processes of POW and POS mining. The First Bitcoin cryptocurrency has a current supply of 20,707,629,255 BIT. It is currently trading on LIVECOIN.net

https://coinmarketcap.com/currencies/first-bitcoin/

Contact us via: info@firstbitcoin.io or visit www.firstbitcoin.io

follow us on Twitter: @1stBitCapital

follow us on Linkedin: www.linkedin.com/company/first-bitcoin-capital-corp/

follow us on FaceBook: www.facebook.com/BITCF/

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as may be disclosed in company's filings. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release. Such forward-looking statements are risks that are detailed in the Company's website and filings.

SOURCE: First Bitcoin Capital Corp.

ReleaseID: 570794

DriveSafety the App that Disables Mobile Phones from Texting and Other Driving Distractions Will Launch in Early 2020

LAS VEGAS, NV / ACCESSWIRE / December 19, 2019 / WebSafety, Inc. (www.websafety.com) (OTCMarkets: WBSI) WebSafety announced that its new DriveSafety app will launch in early 2020 and the new DriveSafety app website has gone live and can be found at www.drivesafetyapp.com.

Rowland Day, Founder and CEO, stated, "The habit of distracted driving and particularly texting while driving is one of society's biggest safety risks as drivers choose to continue these dangerous habits. State governments, safety organizations, car insurance companies, and even AT&T, Verizon, T-Mobile and Sprint are admonishing drivers to refrain from distracted driving. Asking only goes so far-it was time to create a solution to make the world's highways and roads safe. Distracted driving is a needless activity with severe consequences."

"We are excited to launch the DriveSafety app in early 2020. It has been completed and tested. Additionally, the DriveSafety app has wonderful telematics that will help each driver improve their driving habits and may be shared and used by third parties."

"The DriveSafety app will be distributed as a Freemium model allowing for some basic free features with a subscription upgrade to utilize all features. We will have an inexpensive price for the individual, family, or a site-license for an organization which will be negotiated separately."

"We have already received a great deal of interest from car insurance companies, state agencies and other organizations about using DriveSafety."

For more information, please contact:

WebSafety, Inc.
Rowland W. Day II
Tel: 949-642-7816
Email: rday@websafety.com

About WebSafety

WebSafety is a software company that has created mobile apps for the Android and iOS mobile operating systems. The WebSafety app allows parents to monitor questionable and potentially harmful content or a direct predatory exchange that occurs on their child's mobile device. The WebSafety app monitors downloaded apps, websites visited, social media, GPS tracking, allows curfew blocking, and provides real time notifications to the parent. The parent uses a real time dashboard on their desktop, laptop or mobile device to stay informed of their child's activities.

The DriveSafety app disables the mobile device from texting and performing other related distractions while driving a vehicle. The DriveSafety app also supplies driving telematics to the driver or additional concerned parties in order to create a safer driving experience for those in the vehicle and for those on the highways and roads.

SOURCE: WebSafety, Inc.

ReleaseID: 570790

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

Audentes Therapeutics, Inc (NASDAQ:BOLD) related to its sale to Astellas Pharma, Inc. Under the terms of the Agreement, Audentes shareholders will have the right to receive $60.00 in cash for each Audentes common stock owned. Click here for more information: https://www.monteverdelaw.com/case/audentes-therapeutics-inc. It is free and there is no cost or obligation to you.
Instructure, Inc (NYSE:INST) related to its sale to PIV Purchaser, LLC. Under the terms of the Merger, each share of Instructure common stock will automatically be converted into the right to receive $47.60 in cash for each share of Instructure common stock owned. Click here for more information: https://www.monteverdelaw.com/case/instructure-inc. It is free and there is no cost or obligation to you.
TD Ameritrade Holding Corporation (NASDAQ:AMTD) ("Ameritrade") related to its sale to The Charles Schwab Corporation ("Schwab"). Under the terms of the Merger, Ameritrade common stock will be converted into the right to receive 1.0837 shares of Schwab voting common stock for each Ameritrade common stock owned. Click here for more information: https://www.monteverdelaw.com/case/td-ameritrade-holding-corporation. It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC

ReleaseID: 570792

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

REAL Shareholders Click Here: https://www.zlk.com/pslra-1/the-realreal-inc-loss-form?prid=4960&wire=1
YJ Shareholders Click Here: https://www.zlk.com/pslra-1/yunji-inc-loss-form?prid=4960&wire=1
AFI Shareholders Click Here: https://www.zlk.com/pslra-1/armstrong-flooring-inc-loss-form?prid=4960&wire=1

* ADDITIONAL INFORMATION BELOW *

The RealReal, Inc. (NASDAQ:REAL)

REAL Lawsuit on behalf of: investors who purchased all persons and entities who purchased RealReal common stock pursuant and/or traceable to the Company's registration statement issued in connection with the Company's June 27, 2019 initial public offering.
Lead Plaintiff Deadline : January 24, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/the-realreal-inc-loss-form?prid=4960&wire=1

According to the filed complaint, (1) the Company's employees received little training on how to spot fake items; (2) the Company's strict quotas on its employees exacerbated product authentication issues; (3) consequently, the potential for counterfeit or mislabeled items to make it through Company's authentication process was higher than disclosed; and (4) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Yunji Inc. (NASDAQ:YJ)

YJ Lawsuit on behalf of: investors who purchased on behalf of shareholders who purchased or otherwise acquired Yunji American Depositary Shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's May 2019 initial public offering.
Lead Plaintiff Deadline : January 13, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/yunji-inc-loss-form?prid=4960&wire=1

According to the filed complaint, (1) the Company was shifting certain of its sales to its marketplace platform; (2) this supply chain restructuring was likely to disrupt Yunji's relationships with suppliers; (3) this supply chain restructuring was likely to have an adverse impact on the Company's financial results; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Armstrong Flooring, Inc. (NYSE:AFI)

AFI Lawsuit on behalf of: investors who purchased March 6, 2018 – November 4, 2019
Lead Plaintiff Deadline : January 14, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/armstrong-flooring-inc-loss-form?prid=4960&wire=1

According to the filed complaint, during the class period, Armstrong Flooring, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had engaged in channel stuffing to artificially boost sales; (2) the Company's internal control over inventory levels was not effective; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 570786

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Sealed Air Corporation (NYSE:SEE)

Investors Affected : November 5, 2014 – August 6, 2018

A class action has commenced on behalf of certain shareholders in Sealed Air Corporation. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) Sealed Air had hired its auditor, E&Y, pursuant to a conflicted and improper process and in order to help facilitate defendants' efforts to engage in accounting fraud; (b) Sealed Air's deduction of $1.49 billion in connection with the Settlement was indefensible and done for the improper purpose of artificially inflating the Company's financial results; (c) Sealed Air had artificially inflated its earnings, cash flows, and operating income during the Class Period; (d) as a result of the above, Sealed Air's Class Period financial statements were materially false and misleading and not prepared in conformance with GAAP; and (e) as a result of the above, Sealed Air's statements regarding its financial results, business, and prospects were materially misleading.

Shareholders may find more information at https://securitiesclasslaw.com/securities/sealed-air-corporation-loss-submission-form/?id=4959&from=1

UP Fintech Holding Limited (NASDAQ:TIGR)

Investors Affected : all persons and entities that purchased or otherwise acquired: (a) Fintech American Depository Shares pursuant and/or traceable to the Company's initial public offering conducted on or about March 20, 2019; or (b) Fintech securities between March 20, 2019 and May 16, 2019.

A class action has commenced on behalf of certain shareholders in UP Fintech Holding Limited. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Fintech was experiencing a material decrease in commissions because of a negative trend related to risk-averse investors in the market; (ii) Fintech was unable to absorb costs associated with the rapid growth of its business and its status as a publicly listed company on a U.S. exchange; (iii) Fintech was incurring significant additional expenses related to, inter alia, employee headcount and employee compensation and benefits; (iv) all of the foregoing had led to Fintech significantly increasing operating costs and expenses; and (v) as a result, the documents filed by the Company in connection with the initial public offering were materially false and/or misleading and failed to state information required to be stated therein, and the Company's Class Period statements were likewise materially false and/or misleading.

Shareholders may find more information at https://securitiesclasslaw.com/securities/up-fintech-holding-limited-loss-submission-form/?id=4959&from=1

Exelon Corporation (NYSE:EXC)

Investors Affected : February 9, 2019 – November 1, 2019

A class action has commenced on behalf of certain shareholders in Exelon Corporation. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Exelon and/or its employees were engaged in unlawful lobbying activities; (ii) the foregoing increased the risk of a criminal investigation into Exelon; (iii) Exelon subsidiary Commonwealth Edison's revenues were in part the product of unlawful conduct and thus unsustainable; and (iv) that, as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/exelon-corporation-loss-submission-form/?id=4959&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 570785

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Green Dot Corporation (NYSE:GDOT)
Class Period: May 9, 2018 to November 7, 2019
Lead Plaintiff Deadline: February 17, 2020

According to the complaint, Green Dot Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Green Dot's strategy to attract "high-value" long-term customers was at the expense of "one and done" customers; (2) Green Dot's "one and done" customers represented a significant source of revenues in its legacy segment; (3) consequently, Green Dot's strategy was self-sabotaging; and (4) as a result of the foregoing, Defendants' statements about its business and operations were materially false and misleading at all relevant times.

Learn about your recoverable losses in GDOT: http://www.kleinstocklaw.com/pslra-1/green-dot-corporation-loss-submission-form?id=4957&from=1

Wanda Sports Group Company Limited (NASDAQ:WSG)
Class Period: Wanda Sports' securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Wanda Sports' July 26, 2019 initial public offering.
Lead Plaintiff Deadline: January 17, 2020

Throughout the class period, Wanda Sports Group Company Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the lack of major sporting events for its Digital, Production, Sports Solutions ("DPSS") and Spectator Sports segments for its second quarter of 2019, ending before the initial public offering, would negatively impact revenue for the second quarter of 2019; (2) Wanda Sports had suffered a year-over-year decrease in revenue in its second quarter ended June 30, 2019 and would for its fiscal year 2019, primarily related to lower reimbursement revenues accounted for in its DPSS segment and lack of Spectator Sport segment offsets; and (3) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in WSG: http://www.kleinstocklaw.com/pslra-1/wanda-sports-group-company-limited-loss-submission-form?id=4957&from=1

Mylan N.V. (NASDAQ:MYL)
Class Period: May 9, 2018 to May 6, 2019
Lead Plaintiff Deadline: February 14, 2020

During the class period, Mylan N.V. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Mylan's Morgantown facility was in significant violation of the FDA's Current Good Manufacturing Practice regulations; (2) Mylan would need to engage in a massive restructuring and remediation program; (3) Mylan's North American Segment would be substantially impacted by said program, which would in turn materially impact Mylan's financial health; (3) Mylan lacked effective internal control over financial reporting; and (4) as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in MYL: http://www.kleinstocklaw.com/pslra-1/mylan-n-v-loss-submission-form?id=4957&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 570783

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Allakos Inc. ("Allakos" or the "Company") (NASDAQ:ALLK). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/allk.

The investigation concerns whether Allakos and certain of its officers and/or directors have violated federal securities laws.

On December 18, 2019, Seligman Research ("Seligman") published a report characterizing Allakos as "A Suspect Biotech with a Phase 2 Farce, Incredulous Trial Investigators, and Warning Signs of Potential Fraud." Among a litany of other issues, the Seligman report accused Allakos of having "buried the results for the two AK001 studies it conducted, but our research indicates a debacle"; having "a checkered history of conducting small, low-credibility trials, marked by a striking level of what we consider to be discrepancies, omissions, cherry-picking, and other red flags"; and engaging in "[f]lagrant nepotism in key clinical roles". On this news, Allakos's stock price fell $13.25 per share, or 10%, to close at $119.28 on December 18, 2019.

If you are aware of any facts relating to this investigation, or purchased Allakos shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/allk. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 570791

VANCOUVER, BC / ACCESSWIRE / December 19, 2019 / Endocanna Health Inc. ("Endocanna"), a research and development biotechnology company specializing in endocannabinioid DNA testing, and a partly owned subsidiary of Heritage Cannabis Holdings Corp. (CSE:CANN) ("Heritage") partners with Empower Clinics to distribute Endo.dna™ test kits and develop Endo.Aligned™ product formulations.

EMPOWER CLINICS INC. (CSE:CBDT) (OTC:EPWCF) (Frankfurt:8EC) ("Empower" or the "Company"), a vertically integrated and growth-oriented CBD life sciences company, is pleased to announce it has signed an agreement with Endocanna, to licence and distribute Endo.dna™ test kits through its network of clinics and market directly to the Company's 165,000 patient database, and as a standard offering in the Sun Valley Health franchise program.

In addition, the Company plans to partner with Endocanna for their Endo.Aligned™ Formulations program to create, manufacture, produce and distribute specialized CBD based products utilizing the Company-Heritage joint venture extraction centre in Sandy, OR.

"Empower with its clinic network, large patient base and numerous physicians are an ideal distribution partner for Endocanna," said Steven McAuley, Empower's Chairman and CEO. "As we strive to be a leader in patient care and efficacy, having deeper insights about our patients unique DNA profile allows our physicians to provide even more effective cannabis based treatment options. Then, translating that knowledge into new product formulations with Endocanna, will greatly enhance the long-term shareholder value we are creating."

"We are pleased to collaborate with a life sciences company like Empower to develop a custom endocannabinoid-based therapeutic efficacy model," says Len May, Endocanna Health CEO and founder. "Our goal at Endocanna Health is to identify and optimize cannabinoid-based therapies based on an individual's DNA while mitigating potential adverse-events and drug interactions. The data will support DNA validation along with peer-to-peer efficacy feedback, and provides key data to support our mission in facilitating the highest quality, consistent, personalized, endo-aligned cannabinoid products."

The Endo·dna test analyzes specific DNA markers to provide a personalized report, Endo·Decoded, that can help guide decisions for choosing the right cannabinoid products with the right:

Formulation – full-spectrum or broad-spectrum
Dose – the amount you take and when you take it
Delivery – flower, aerosol, vaping, sublingual (under the tongue), topical, or edible

The Endo·Decoded report helps consumers uncover optimal cannabinoid ratios and terpene profiles for their specific genetic makeup. Endocanna's customized endocannabinoid genomics super-chip and algorithm provides consumers with:

Ideal cannabinoid ratios and terpene profiles, methods of delivery or consumption, and dosing.
Suggestions for specific terpenes and cannabinoids to seek out or to avoid.
Individualized risks or benefits from using cannabinoids.
Suggestions commercially available products and brands most aligned with individual genetics and formulations suggestions.

ABOUT EMPOWER CLINICS INC.

Empower is a leading owner/operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative uses of medical cannabis. It is expected that Empower's proprietary product line "Sollievo" will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based product options in its clinics, online and at major retailers. With over 165,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirement's in 2019 and beyond.

ABOUT ENDOCANNA HEALTH INC.

Endocanna is a biotechnology research company that utilizes a patent-pending process for its cannabinoid DNA variant report, Endo·Decoded™ and product- matching algorithm, Endo·Aligned™. Endo·dna™ provides two ways to submit DNA for analysis, either collected through a simple saliva swab or a direct upload of genetic data files from popular DNA testing services like Ancestry, 23andMe, Family TreeDNA, or MyHeritageDNA. Endocanna's HIPAA compliant and secure health and wellness portal, Mydna.live, provides customers with a personalized experience where they can access their Endo·Decoded report and Endo·Aligned formulation suggestions for their specific genotype. In 2019, cannabis producer Heritage Cannabis Holdings (CSE:CANN)(OTC:HERTF) acquired a 30 percent stake in Endocanna Health Inc.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steve Low
Boom Capital Markets
steve@boomcapitalmarkets.com
647-620-5101

Investors: Steven McAuley
CEO
s.mcauley@empowerclinics.com
604-789-2146

For French inquiries: Remy Scalabrini, Maricom Inc., E: rs@maricom.ca, T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include statements regarding: endocanna agreement; the Company's intention to open a hemp-based CBD extraction facility; the expected product development and manufacturing; the expected benefits to the Company and its shareholders as a result of the proposed JV. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including that: Heritage and Empower may be unable to agree on terms of a definitive agreement with respect to the JV; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed JV or extraction facility; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

SOURCE: Endocanna Health Inc.

ReleaseID: 570624

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

QUAD Shareholders Click Here: https://www.zlk.com/pslra-1/quad-graphics-inc-loss-form?prid=4961&wire=1
BAX Shareholders Click Here: https://www.zlk.com/pslra-1/baxter-international-inc-loss-form?prid=4961&wire=1
FCAU Shareholders Click Here: https://www.zlk.com/pslra-1/fiat-chrysler-automobiles-n-v-loss-form?prid=4961&wire=1

* ADDITIONAL INFORMATION BELOW *

Quad/Graphics, Inc. (NYSE:QUAD)

QUAD Lawsuit on behalf of: investors who purchased February 21, 2018 – October 29, 2019
Lead Plaintiff Deadline : January 6, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/quad-graphics-inc-loss-form?prid=4961&wire=1

According to the filed complaint, during the class period, Quad/Graphics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's book business in United States was underperforming; (2) as a result, the Company was likely to divest its book business; (3) the Company was unreasonably vulnerable to decreases in market prices; (4) to remain financially flexible while market prices decreased, the Company was likely to cut its quarterly dividend and expand its cost reduction programs; and (5) as a result of the foregoing, positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Baxter International Inc. (NYSE:BAX)

BAX Lawsuit on behalf of: investors who purchased February 21, 2019 – October 23, 2019
Lead Plaintiff Deadline : January 24, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/baxter-international-inc-loss-form?prid=4961&wire=1

According to the filed complaint, during the class period, Baxter International Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) certain intra-Company transactions, undertaken for the purpose of generating foreign exchange gains and losses, used foreign exchange rate conventions that were not in accordance with GAAP and enabled intra-Company transactions to be undertaken after the related exchange rates were already known; (2) the Company lacked effective internal control over financial reporting; (3) as a result, the Company's financial statements were misstated and would likely require correction or amendment; (4) due to the Company's internal investigation, Baxter would not be able to file its quarterly report for the period ending September 30, 2019, with the SEC on Form 10-Q in a timely manner; and (5) as a result of the foregoing, Defendants' statements about the Company's business and operations lacked a reasonable basis.

Fiat Chrysler Automobiles N.V. (NYSE:FCAU)

FCAU Lawsuit on behalf of: investors who purchased February 26, 2016 – November 20, 2019
Lead Plaintiff Deadline : January 31, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/fiat-chrysler-automobiles-n-v-loss-form?prid=4961&wire=1

According to the filed complaint, during the class period, Fiat Chrysler Automobiles N.V. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company employed a bribery scheme to obtain favorable terms in its collective bargaining agreement with United Automobile, Aerospace and Agricultural Implement Workers of America; (2) high-ranking Fiat officials were aware of and authorized the scheme; and (3) as a result, Defendants' statements about Fiat's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 570787